MATINAS BIOPHARMA HLDGS INC's ticker is MTNB and the CUSIP is 576810105. A total of 72 filers reported holding MATINAS BIOPHARMA HLDGS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $26,053 | +100.4% | 52,106 | +150.5% | 0.00% | – |
| Q3 2022 | $13,000 | -89.1% | 20,801 | -82.4% | 0.00% | – |
| Q4 2021 | $119,000 | -50.6% | 118,039 | -36.1% | 0.00% | – |
| Q3 2021 | $241,000 | -27.0% | 184,865 | -41.3% | 0.00% | – |
| Q1 2021 | $330,000 | +127.6% | 314,715 | +194.2% | 0.00% | – |
| Q4 2020 | $145,000 | +158.9% | 106,962 | +45.6% | 0.00% | – |
| Q3 2020 | $56,000 | -37.8% | 73,439 | -37.1% | 0.00% | – |
| Q2 2020 | $90,000 | +42.9% | 116,841 | +320.6% | 0.00% | – |
| Q4 2019 | $63,000 | +3.3% | 27,780 | -73.2% | 0.00% | – |
| Q4 2018 | $61,000 | +1120.0% | 103,597 | +820.1% | 0.00% | – |
| Q2 2018 | $5,000 | -73.7% | 11,259 | -54.2% | 0.00% | – |
| Q1 2018 | $19,000 | -63.5% | 24,604 | -45.0% | 0.00% | – |
| Q4 2017 | $52,000 | -14.8% | 44,736 | +23.9% | 0.00% | – |
| Q2 2017 | $61,000 | – | 36,117 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 1,429,532 | $1,944,000 | 0.61% |
| Boxer Capital, LLC | 11,478,634 | $15,611,000 | 0.50% |
| Vivo Capital, LLC | 6,451,612 | $8,774,000 | 0.39% |
| Philadelphia Financial Management of San Francisco, LLC | 740,861 | $1,008,000 | 0.26% |
| DCF Advisers, LLC | 305,299 | $415,000 | 0.17% |
| Main Street Financial Solutions, LLC | 400,826 | $545,000 | 0.11% |
| Platform Technology Partners | 158,660 | $216,000 | 0.10% |
| STALEY CAPITAL ADVISERS INC | 600,000 | $816,000 | 0.05% |
| MONECO Advisors, LLC | 50,000 | $81,000 | 0.04% |
| CCG WEALTH MANAGEMENT, LLC | 30,000 | $41,000 | 0.04% |